As with all products, we will keep its safety under close review The Medicines and Healthcare products Regulatory Agency ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved polihexanide (Akantior) to treat acanthamoeba keratitis. Acanthamoeba keratitis is an infection of the cornea, the clear ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved guselkumab (Tremfya) to treat Crohn’s disease and ulcerative colitis (UC). The approval was granted on 16th May, 2025 to ...

The Royal Devon University Hospitals NHS Foundation Trust, which runs North Devon District Hospital, currently has 396 ...

Bad reactions to popular weight-loss drugs, including Ozempic and Wegovy, are on track to soar by more than 350 per cent within a year, new data has suggested.

Britons have been urged to check their pill drawer following an urgent medicine recall due to contamination fears. Aspen ...

Patients and healthcare professionals are encouraged to report adverse reactions through the MHRA’s Yellow Card scheme ... The patient information leaflet and summary of product characteristics ...

The innovative, credit-card-sized single QR code gives patients and their families instant access to essential information by ... across different websites and leaflets. “The idea was to bring ...

You can find patient information leaflets for each drug on this website. You can report any side effect you have to the Medicines Health and Regulatory Authority (MHRA) as part of their Yellow Card ...

You are entitled to request access to all personal information including your health record held by Murrumbidgee Local Health District (LHD). We are committed to safeguarding the privacy of ...

The personal information of about 38,000 patients of a UChicago Medicine medical group may have been exposed in a cybersecurity incident involving one of the group’s vendors. UCM Medical Group ...